Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01683084 · ClinicalTrials.gov registry record · Phase 4
Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms
A Phase 4 study, sponsored by Palo Alto Veterans Institute for Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
NCT01683084: Completed Phase 4 study, sponsored by Palo Alto Veterans Institute for Research.
NCT01683084 is a Phase 4 study that has completed, run by Palo Alto Veterans Institute for Research. The registered enrollment target is 22 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01683084, a Phase 4 study, has completed, sponsored by Palo Alto Veterans Institute for Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if telmisartan is effective in slowing the progression of abdominal aortic aneurysms and reducing circulating concentrations of Abdominal Aortic Aneurysms (AAA) biomarkers.
Interventions
- DRUG Placebo
- DRUG Telmisartan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2012-09-19 |
| Est. Completion | 2018-11-10 |
| Phase | Phase 4 |
What the finished NCT01683084 record still lists
NCT01683084 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01683084 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01683084 about?
NCT01683084 is a clinical study titled "Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms". The purpose of this study is to determine if telmisartan is effective in slowing the progression of abdominal aortic aneurysms and reducing circulating concentrations of Abdominal Aortic Aneurysms (AAA) biomarkers.
What is the current status of trial NCT01683084?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2012-09-19. Estimated completion is 2018-11-10.
What interventions are being tested in trial NCT01683084?
The interventions under investigation include: Placebo (DRUG), Telmisartan (DRUG).
Who is sponsoring clinical trial NCT01683084?
This trial is sponsored by Palo Alto Veterans Institute for Research, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01683084's enrollment target sits among peer trials
22 1731st of 2000 higher than 259 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI